2022年关于功能性便秘的临床实践指南的首尔共识.
Young Sin Cho1, Yoo Jin Lee2, Jeong Eun Shin3
1Division of Gastroenterology, Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Chungcheongnam-do, Korea.
Journal of neurogastroenterology and motility
|July 7, 2023
概括
新的指导方针为诊断和管理慢性便秘提供了基于证据的建议. 这包括评估功能性便秘的新药和常规药,帮助临床决策.
科学领域:
- 胃肠病学 胃肠病学
- 临床实践指南 临床实践指南
背景情况:
- 慢性便秘是一种普遍的消化系统疾病,具有多种症状.
- 像布里斯托尔形尺度这样的客观评估工具有助于诊断.
- 生理学测试对于耐火病例和可疑的排便障碍有价值.
研究的目的:
- 修订和更新功能性便秘诊断和管理的基于证据的指导方针.
- 提供基于系统审查和元分析的建议.
- 为临床医生和患者提供最佳治疗策略的信息.
主要方法:
- 现有文献的系统审查和元分析.
- 药理学剂的评估,包括新药 (卢比普罗,林纳克洛) 和传统的药.
- 制定了34项基于证据的建议,涵盖定义,流行病学,诊断和管理.
主要成果:
- 这些指南讨论了各种治疗选择的好处和注意事项.
- 建议涵盖功能性便秘的诊断标准和治疗方法.
- 分析为药理干预措施的评估提供了信息.
结论:
- 这些指导方针为管理功能性便秘提供了一个全面的框架.
- 临床医生和患者可以利用这些建议进行知情决策.
- 更新的指南反映了关于便秘的诊断和治疗的新证据.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
225
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
225
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
195
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
195
Irritable Bowel Syndrome III: Medical and Nursing Management
245
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
245
Chronic Bowel Disorders: Introduction
489
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
489
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
314
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
314
Assessment of the Rectum and Anus
283
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
283


